中草药

基于细胞药动学的斑蝥素/黄芩苷配伍抗肝癌增效机制研究

PDF下载

中草药 | 药理与临床 2026,57(1): 185-193

收起

中草药 |药理与临床 2026 , 57 (1) : 185 -193

基于细胞药动学的斑蝥素/黄芩苷配伍抗肝癌增效机制研究

全屏

黄莉^1,2, 金凯³, 王晨阳¹, 肖望重¹, 王滔¹, 郑飘⁴, 王璐¹, 马杰⁵, 刘平安²

作者信息

通讯作者:

刘平安

作者简介:

黄莉: 黄莉,副主任药师,硕士生导师,研究方向为中药质量控制与新药研发。E-mail:Huanglily0101@hnucm.edu.cn

Synergistic anti-hepatocarcinoma mechanism of cantharidin/baicalin compatibility based on cellular pharmacokinetics

HUANG Li, JIN Kai, WANG Chenyang, XIAO Wangzhong, WANG Tao, ZHENG Piao, WANG Lu, MA Jie, LIU Ping'an

Affiliations

doi: 10.7501/j.issn.0253-2670.2026.01.018

文章导航

摘要

收起

目的基于细胞药动学探究斑蝥素与黄芩苷配伍在亚细胞水平的分布规律，阐明其抗肝癌的增效机制。方法以人肝癌HepG2细胞为模型，采用超高效液相色谱-串联质谱（ultra-high performance liquid chromatography-tandem mass spectrometry，UPLC-MS/MS）定量分析单药（斑蝥素6 μg/mL、黄芩苷30 μg/mL）及配伍组（斑蝥素6 μg/mL＋黄芩苷30 μg/mL）给药后12 h内，整体细胞及细胞核、线粒体、内质网和溶酶体各细胞器中药物浓度的动态变化，并应用Phoenix WinNonlin软件非房室模型计算药动学参数。结果在整体细胞水平，配伍使斑蝥素的胞内药时曲线下面积（area under the curve，AUC₀～t）增加48.9%，清除率降低（P＜0.05），但未显著影响黄芩苷的药动学行为。在亚细胞层面，配伍使斑蝥素与黄芩苷在细胞核、溶酶体、线粒体、内质网内的AUC₀～t分别增加了93.5%、46.4%、38.3%、52.3%和68.4%、40.0%、41.0%、46.7%（P＜0.05、0.01）。此外，配伍后2种药物在线粒体内达峰时间（tmax）提前，且斑蝥素在内质网中的平均驻留时间（mean residence time，MRT₀～t）显著延长（P＜0.01），表明两者配伍实现了时空协同的药物递送。结论斑蝥素/黄芩苷配伍可通过协同优化药物在细胞核、线粒体、内质网及溶酶体等关键亚细胞结构的分布，进而可能通过诱导DNA损伤、加速线粒体介导细胞凋亡及促进内质网应激等途径，增强抗肝癌效果，为基于细胞器靶向的中药配伍设计提供了理论依据。

关键词

斑蝥素 / 黄芩苷 / 中药配伍 / 抗肝癌 / 细胞药动学 / 亚细胞分布

Abstract

收起

Objective To investigate the subcellular distribution patterns of the combination of cantharidin (CTD) and baicalin (BA) based on cell pharmacokinetics and elucidate the synergistic mechanism against hepatocellular carcinoma. Methods Using human hepatoma HepG2 cells as the model, the dynamic concentrations of the drugs in whole cells and organelles (nucleus, mitochondria, endoplasmic reticulum, and lysosomes) over 12 h after administration of single drugs (CTD 6 μg/mL, BA 30 μg/mL) and their combination (CTD 6 μg/mL + BA 30 μg/mL) were quantitatively analyzed by ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Pharmacokinetic parameters were calculated using a non-compartmental model with Phoenix WinNonlin software. Results At the whole-cell level, the combination increased the intracellular area under the curve (AUC₀_—_t) of CTD by 48.9% and decreased its clearance (P < 0.05), but did not significantly affect the pharmacokinetics of BA. At the subcellular level, the combination significantly increased the AUC₀_—_t of CTD and BA in nucleus, lysosome, mitochondria and endoplasmic reticulum by 93.5%, 46.4%, 38.3%, 52.3%, and 68.4%, 40.0%, 41.0%, and 46.7%, respectively (P < 0.05, 0.01). Furthermore, the time to reach peak concentration (t_max) for both drugs in mitochondria was earlier in the combination group, and the mean residence time (MRT₀_—_t) of CTD in the endoplasmic reticulum was significantly prolonged (P < 0.01), indicating a spatiotemporally synergistic drug delivery optimization. Conclusions The combination of CTD and BA could synergistically optimize the distribution of drugs in key subcellular structures such as nucleus, mitochondria, endoplasmic reticulum and lysosomes, and may enhance the anti-hepatocellular carcinoma effect by inducing DNA damage, accelerating mitochondria-mediated apoptosis and promoting endoplasmic reticulum stress, which provides a theoretical basis for the design of traditional Chinese medicine combinations based on organelle targeting.

Key words

cantharidin / baicalin / traditional Chinese medicine combination / anti-hepatocellular carcinoma / cellular pharmacokinetics / subcellular distribution

引用本文

黄莉, 金凯, 王晨阳, 肖望重, 王滔, 郑飘, 王璐, 马杰, 刘平安. 基于细胞药动学的斑蝥素/黄芩苷配伍抗肝癌增效机制研究. 中草药, 2026 , 57 (1) : 185 -193 . DOI: 10.7501/j.issn.0253-2670.2026.01.018

HUANG Li, JIN Kai, WANG Chenyang, XIAO Wangzhong, WANG Tao, ZHENG Piao, WANG Lu, MA Jie, LIU Ping'an. Synergistic anti-hepatocarcinoma mechanism of cantharidin/baicalin compatibility based on cellular pharmacokinetics[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (1) : 185 -193 . DOI: 10.7501/j.issn.0253-2670.2026.01.018

基金

收起

湖南省卫生健康委员会项目 (202213014042); 湖南省教育厅优秀青年项目 (22B0375); 湖南省自然科学基金项目 (2022JJ80023); 国家中医药管理局全国老药工传承工作室建设项目 (国中医药人教函[2024]255号)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

Lohitesh K, Chowdhury R, Mukherjee S. Resistance a major hindrance to chemotherapy in hepatocellular carcinoma:An insight[J]. Cancer Cell Int, 2018, 18(1):44.
Yang C, Li D, Ko C N, et al. Active ingredients of traditional Chinese medicine for enhancing the effect of tumor immunotherapy[J]. Front Immunol, 2023, 14:1133050.
Zhou Y, Wang Z, Ren S, et al. Mechanism of action of protopanaxadiol ginsenosides on hepatocellular carcinoma and network pharmacological analysis[J]. Chin Herb Med,2024, 16(4):548-557.
Yan J, Deng X L, Ma S Q, et al. Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response[J]. BMC Complement Med Ther, 2023, 23(1):160.
Wang R L, Wang C Y, Lu L H, et al. Baicalin and baicalein in modulating tumor microenvironment for cancer treatment:A comprehensive review with future perspectives[J]. Pharmacol Res, 2024, 199:107032.
侯晓杰,张建锋,侯长周,等.黄芩苷药理活性和作用机制研究进展[J]. 药物评价研究, 2024, 47(11):2688-2696.
李敏.斑蝥酸钠维生素B6注射液联合痰热清注射液治疗癌性发热[J]. 华西医学, 2010, 25(4):753-754.
Huang L, Yang Z L, He Y, et al. Development of cantharidin/baicalin co-delivery system based on mitochondrial targeting strategy for enhanced hepatocellular carcinoma therapy[J]. Appl Mater Today,2024, 40:102374.
高昱,杨磊,金凯,等.叶酸修饰的斑蝥素/黄芩苷脂质体在正常大鼠与荷瘤大鼠体内的药动学及组织分布差异研究[J]. 中国药学杂志, 2025, 60(1):39-46.
Lv L J, You Y Y, Liu Y J, et al. Advanced research in cellular pharmacokinetics and its cutting-edge technologies[J]. Curr Pharm Des, 2022, 28(37):3095-3104.
Li Q, Zhou T, Wu F, et al. Subcellular drug distribution:Mechanisms and roles in drug efficacy, toxicity, resistance,and targeted delivery[J]. Drug Metab Rev, 2018, 50(4):430-447.
Hsia T C, Yu C C, Hsu S C, et al. Cantharidin induces apoptosis of H460 human lung cancer cells through mitochondria-dependent pathways[J]. Int J Oncol, 2014,45(1):245-254.
Wang Z X, Jiang C P, Chen W B, et al. Baicalein induces apoptosis and autophagy via endoplasmic reticulum stress in hepatocellular carcinoma cells[J]. Biomed Res Int,2014, 2014:732516.
Zhang Z Q, Yue P F, Lu T Q, et al. Role of lysosomes in physiological activities, diseases, and therapy[J]. J Hematol Oncol, 2021, 14(1):79.
Xing J, Chen X Y, Zhong D F. Absorption and enterohepatic circulation of baicalin in rats[J]. Life Sci,2005, 78(2):140-146.
Feng S M, Zhu J, Xia K S, et al. Cantharidin inhibits antiapoptotic bcl-2 family proteins and induces apoptosis in human osteosarcoma cell lines MG-63 and MNNG/HOS via mitochondria-dependent pathway[J]. Med Sci Monit,2018, 24:6742-6749.
Kuo J H, Shih T Y, Lin J P, et al. Cantharidin induces DNA damage and inhibits DNA repair-associated protein expressions in TSGH8301 human bladder cancer cell[J]. Anticancer Res, 2015, 35(2):795-804.
Huang W W, Ko S W, Tsai H Y, et al. Cantharidin induces G2/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways[J]. Int J Oncol,2011, 38(4):1067-1073.
王燕,蒋汝荷,余玥,等.斑蝥素及其衍生物抗癌作用机制的研究进展[J]. 复旦学报:医学版, 2024, 51(4):620-631.
刘梦珂,纪濛濛,程林,等.黄芩苷抗肿瘤作用机制的研究进展[J]. 上海交通大学学报:医学版, 2021,41(2):246-250.
Zhao M, Antunes F, Eaton J W, et al. Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis[J]. Eur J Biochem, 2003, 270(18):3778-3786.
Wang L, Feng T, Su Z L, et al. Latest research progress on anticancer effect of baicalin and its aglycone baicalein[J]. Arch Pharm Res, 2022, 45(8):535-557.
Chang C, Zhu Y Q, Tang X Y, et al. The anti-proliferative effects of norcantharidin on human HepG2 cells in cell culture[J]. Mol Biol Rep, 2011, 38(1):163-169.
Bravo-Sagua R, Rodriguez A E, Kuzmicic J, et al. Cell death and survival through the endoplasmic reticulummitochondrial axis[J]. Curr Mol Med, 2013, 13(2):317-329.
石珂,周泓妍,张涵,等.薄膜超声法制备共载人参皂苷Rg3和五味子乙素脂质体及其质量评价[J]. 中草药, 2025, 56(21):7725-7735.
朱巧凤,周蓓,吴燕春,等.基于网络药理学-分子对接及实验研究探讨肉桂醛联合姜黄素抗肝细胞癌的作用机制[J]. 天津中医药, 2024, 41(8):1055-1062.
Zhang S, Tang D C, Zang W H, et al. Synergistic inhibitory effect of traditional Chinese medicine astragaloside IV and curcumin on tumor growth and angiogenesis in an orthotopic nude-mouse model of human hepatocellular carcinoma[J]. Anticancer Res, 2017, 37(2):465-473.

2026年第57卷第1期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.01.018

接收时间：2025-09-07
首发时间：2026-09-09

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2025-09-07

基金

作者信息

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.01.018

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT